Form 4 for MRNA Moderna
Accepted 2024-12-02 00:00:00 ET · period of report 2024-11-27 · accession 0001127602-24-028297 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-12-02 | 2024-11-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | — | +2,981 | 18.5K | +19% | — |
| D | 2024-12-02 | 2024-11-29 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $42.79 | -1,418 | 19.7K | -7% | -$60.7K |
| DM | 2024-12-02 | 2024-11-27 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -2,981 | 2,959 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-27 | M | A | 2,652 | — | 21,135 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-11-27 | M | A | 329 | — | 18,483 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Common | Common Stock | 2024-11-29 | S | D | 1,418 | $42.79 | 19,717 | D | — | — | |
| 4 | Derivative | Restricted Stock Units | 2024-11-27 | M | D | 2,652 | $0.00 | 2,653 | D | — · — to — | 2,652 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter. |
| 5 | Derivative | Restricted Stock Units | 2024-11-27 | M | D | 329 | $0.00 | 2,959 | D | — · — to — | 329 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |